Physician profile
Jacob Levy
NPI 1972180636
$696.77
in general payments reported to CMS, 2019-2025
9 companies · $405 in 2025
The $405 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.83 · 2022: $36.24 · 2023: $83.16 · 2024: $146 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $634.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $205.77 | 2025 | |
| Abbvie INC. | $127.62 | 2025 | |
| Mentor Worldwide LLC | $107.97 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Medtronic, INC. | $101.04 | 2021-2024 | V-Loc 180, Signia |
| Ethicon US, LLC | $71.74 | 2025 | Evarrest |
| Mozarc Medical US LLC | $29.44 | 2023 | Palindrome |
| Kci USA, INC. | $19.14 | 2022 | |
| Integra Lifesciences Corporation | $17.10 | 2022 | |
| Pfizer INC. | $16.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.